Literature DB >> 18606679

Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents.

Constanze Breithaupt1, Beatrix Schäfer, Hannah Pellkofer, Robert Huber, Christopher Linington, Uwe Jacob.   

Abstract

Conformational epitopes of myelin oligodendrocyte glycoprotein (MOG) provide a major target for demyelinating autoantibodies in experimental autoimmune encephalomyelitis and recent studies indicate that a similar situation may exist in multiple sclerosis. We recently solved the crystal structure of the extracellular domain of MOG (MOG(ex)) in complex with a Fab derived from the demyelinating mAb 8-18C5 and identified the conformational 8-18C5 epitope on MOG that is dominated by the surface exposed FG loop of MOG. To determine the importance of this epitope with regard to the polyclonal Ab response to MOG(ex) we investigated the effects of mutating His(103) and Ser(104), the two central amino acids of the FG loop, on Ab binding. Mutation of these two residues reduced binding of a panel of eight demyelinating conformation-dependent mAbs to <20% compared with binding to wild-type MOG(ex), whereas substitution of amino acids that do not contribute to the 8-18C5 epitope had only a minor effect on Ab binding. The same restriction was observed for the polyclonal MOG-specific Ab response of MOG DNA-vaccinated BALB/c and SJL/J mice. Our data demonstrate that the pathogenic anti-MOG Ab response primarily targets one immunodominant region centered at the FG loop of MOG. Comparison of the structure of MOG(ex) with the structures of related IgV-like domains yields a possible explanation for the focused Ab response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606679     DOI: 10.4049/jimmunol.181.2.1255

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.

Authors:  Marie Cathrin Mayer; Edgar Meinl
Journal:  Ther Adv Neurol Disord       Date:  2012-05       Impact factor: 6.570

2.  Accumulation of reactivity to MBP sensitizes TRAIL mediated oligodendrocyte apoptosis in adult sub cortical white matter in a model for human multiple sclerosis.

Authors:  Sajad Mir; Farrah Ali; Deepika Chauhan; Rajesh Arora; Haider A Khan
Journal:  Metab Brain Dis       Date:  2015-10-19       Impact factor: 3.584

3.  A missense mutation in myelin oligodendrocyte glycoprotein as a cause of familial narcolepsy with cataplexy.

Authors:  Hyun Hor; Luca Bartesaghi; Zoltán Kutalik; José L Vicário; Clara de Andrés; Corinne Pfister; Gert J Lammers; Nicolas Guex; Roman Chrast; Mehdi Tafti; Rosa Peraita-Adrados
Journal:  Am J Hum Genet       Date:  2011-09-09       Impact factor: 11.025

4.  Autoantigen conformation influences both B- and T-cell responses and encephalitogenicity.

Authors:  Katrien L de Graaf; Monika Albert; Robert Weissert
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

5.  Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis.

Authors:  Til Menge; Patrice H Lalive; H Christian von Büdingen; Claude P Genain
Journal:  J Neuroinflammation       Date:  2011-11-17       Impact factor: 8.322

6.  The glycan role in the glycopeptide immunogenicity revealed by atomistic simulations and spectroscopic experiments on the multiple sclerosis biomarker CSF114(Glc).

Authors:  Agostino Bruno; Mario Scrima; Ettore Novellino; Gerardino D'Errico; Anna Maria D'Ursi; Vittorio Limongelli
Journal:  Sci Rep       Date:  2015-03-17       Impact factor: 4.379

7.  Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis.

Authors:  Annie Elong Ngono; Maud Lepetit; Markus Reindl; Alexandra Garcia; Flora Guillot; Athénaïs Genty; Mélanie Chesneau; Marion Salou; Laure Michel; Fabienne Lefrere; Kathrin Schanda; Berthe-Marie Imbert-Marcille; Nicolas Degauque; Arnaud Nicot; Sophie Brouard; David-Axel Laplaud; Jean-Paul Soulillou
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

Review 8.  The primate autoimmune encephalomyelitis model; a bridge between mouse and man.

Authors:  Bert A 't Hart; Yvette van Kooyk; Jeroen J G Geurts; Bruno Gran
Journal:  Ann Clin Transl Neurol       Date:  2015-03-18       Impact factor: 4.511

9.  MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies.

Authors:  Nicolas Molnarfi; Ulf Schulze-Topphoff; Martin S Weber; Juan C Patarroyo; Thomas Prod'homme; Michel Varrin-Doyer; Aparna Shetty; Christopher Linington; Anthony J Slavin; Juan Hidalgo; Dieter E Jenne; Hartmut Wekerle; Raymond A Sobel; Claude C A Bernard; Mark J Shlomchik; Scott S Zamvil
Journal:  J Exp Med       Date:  2013-12-09       Impact factor: 14.307

10.  Engineered clearing agents for the selective depletion of antigen-specific antibodies.

Authors:  Siva Charan Devanaboyina; Priyanka Khare; Dilip K Challa; Raimund J Ober; E Sally Ward
Journal:  Nat Commun       Date:  2017-05-31       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.